News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
227 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Business
Innovus Pharma Announces Agreement With ACON Laboratories
ACON Labs is a San Diego-based diagnostic product manufacturer who will supply Innovus Pharma with its FDA cleared Urinary Tract Infection test strips.
November 9, 2017
·
7 min read
Biotech Beach
Nexalin Technology Demonstrates Success in the Treatment of Depression
Nexalin Technology is pleased to announce the initiation of clinical trials designed by the University of Pennsylvania to investigate the effectiveness of the Nexalin transcranial stimulation (TACS) for major depressive disorder.
November 9, 2017
·
4 min read
FDA
FDA Green Lights Neusoft Medical’s NeuViz Prime CT Scanner
The latest advance in more than 20 years of continual CT innovation.
November 9, 2017
·
2 min read
Genetown
Avedro Marks the First Anniversary of Availability of the Only FDA Approved Corneal Cross-Linking Treatment in The U.S.
Avedro, today marked the one year anniversary of the U.S. commercial availability of Photrexa Viscous and Photrexa.
November 9, 2017
·
4 min read
Business
Prometic to Report its Third Quarter 2017 Financial Results and to Hold Conference Call / Webcast
Prometic will host a conference call at 11:00am (ET) on Tuesday November 14, 2017.
November 9, 2017
·
3 min read
Business
Alliqua BioMedical Reports Third Quarter of Fiscal Year 2017 Financial Results and Increases Fiscal Year 2017 Financial Outlook
Q3’17 Product revenue from continuing operations increased 14% year-over-year, led by Biologics growth of 70% year-over-year.
November 9, 2017
·
19 min read
Genetown
Ultivue Launches InSituPlex Services for Whole Slide, High Definition Spatial Multiplex Tissue Biomarker Analysis
The service offering relies on the company’s proprietary InSituPlex technology that supports unbiased biomarker analysis in tissue at a high level of multiplex and with high spatial resolution.
November 9, 2017
·
2 min read
Biotech Beach
TearLab Corporation Begins Trading on OTCQB
As previously disclosed, the Company was unable to regain compliance with NASDAQ Listing Rule 5550(b) prior to November 6, 2017.
November 9, 2017
·
2 min read
Apellis Pharmaceuticals Announces Pricing of Initial Public Offering
Apellis announced the pricing of its initial public offering of 10,714,000 shares of common stock at a public offering price of $14.00 per share.
November 9, 2017
·
2 min read
Business
BeyondSpring Reports Third Quarter 2017 Operational and Financial Results
Cash, cash equivalents and short-term investments were $40.7 million as of September 30, 2017, compared to $49.0 million at June 30, 2017.
November 9, 2017
·
8 min read
Previous
13 of 23
Next